N4P — N4 Pharma Balance Sheet
0.000.00%
- £3.75m
- £3.12m
- £0.01m
Annual balance sheet for N4 Pharma, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 3.56 | 1.78 | 1.92 | 1.03 | 0.626 |
Net Total Receivables | 0.255 | 0.551 | 0.21 | 0.176 | 0.135 |
Prepaid Expenses | |||||
Total Current Assets | 3.83 | 2.34 | 2.17 | 1.21 | 0.776 |
Net Goodwill | |||||
Total Assets | 3.83 | 2.34 | 2.17 | 1.28 | 0.776 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.169 | 0.213 | 0.078 | 0.082 | 0.124 |
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Liabilities | 0.169 | 0.213 | 0.078 | 0.148 | 0.128 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 3.66 | 2.13 | 2.09 | 1.13 | 0.648 |
Total Liabilities & Shareholders' Equity | 3.83 | 2.34 | 2.17 | 1.28 | 0.776 |
Total Common Shares Outstanding |